Organoids derived from patient tissues support personalized cancer treatment
Chicago (May 2, 2023) — Researchers created organoids from cancer cells to reduce the need for trial and error in identifying effective cancer treatments in one of many cancer studies scheduled for presentation this week at Digestive Disease Week® (DDW) 2023.
Below are summaries of three studies scheduled for DDW, their embargo times and presentation times at the meeting in Chicago May 6-9.
Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application
Chemotherapy is often the only treatment option for biliary tract cancer, which is usually found at a late stage, making it one of the most lethal ...










